Article metrics

PDF

Original article
Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: December 2017 to January 2018

AbstractFullPdf
Dec 2017686824
Jan 2018329334213
Total397402237